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Abstract 
The effect of platelet-delved growth factor (PDGF) on Rap1 expression was investigated in rat vascular smooth muscle cells (SMC). First, evidence 
for Rap1 proteins was shown by their: (i) detection in membranes using a specific anti-Rap1 antibody, (ii) typical shift in electrophoretic mobility 
as a consequence of reduction, and (iii) CAMP-induced phosphorylation and immunoprecipitation. Then, the mitogenic activity of 10 @ml PDGF 
AA and BB for 48 h, resulting in a 2- and 5-fold increase in [3H]thymidine incorporation, was correlated with that of total Rap1 protein expression 
which was found to be 99% ? 36% and 260% zh 70%, respectively. Further time-course studies established that this up-regulation of Rap1 proteins 
was only observed after 48 h of PDGF BB treatment. Lastly, comparative RT-PCR of both rapla and raplb mRNAs showed that PDGF BB also 
up-regulated the rapla mRNA species, which was l.bfold increased in contrast with the raplb mRNA species. It is concluded that the PDGF 
BB-induced SMC proliferation is associated with an up-regulation of Rapla protein. 
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I. Introduction 
The cell proliferation induced by growth factors in- 
volves a cascade of intracellular signal transduction 
mechanisms leading to cell mitosis. The existence of mul- 
tiple signalling pathways is supported by the cooperation 
between oncoproteins like cytoplasmic protein kinases, 
GTP-binding proteins, or nuclear transcription factors. 
Among these is the small molecular weight GTP binding 
Ras-p2 1 oncoprotein which has been shown to play a key 
role in the signal transduction induced by growth factors 
leading to cell proliferation [1,2]. 
*Corresponding author. Fax: (33) (1) 49 95 85 79. 
Abbreviations: rap, Ras-proximate; PDGF, platelet-derived growth fac- 
tor; SMC, smooth muscle cells; PRA, CAMP-dependent protein 
kinase; C. Sub., catalytic subunit of PKA; HEPES, 4-(2-hydroxy- 
ethyl)- 1 -piperazine ethanesulfonic acid; EGTA, [ethylene bis 
(oxyethylenenitrilo)]tetraacetic acid; DTT, dithiothreitol; SBTI, soy- 
bean trypsin inhibitor; SDS, sodium dodecyl sulfate; PAGE, poly- 
acrylamide gel electrophoresis; RT-PCR, reverse transcription-PCR, 
SERCA, sarcolendoplasmic reticulum Ca” ATPase; MMLV, murine 
Maloney leukemia virus; SSC, sodium salt citrate; GAP, GTPase acti- 
vating protein. 
In contrast, little is known concerning the down-regu- 
lation of cell proliferation. Interestingly, a cDNA was 
initially characterized in NIH-3T3 cells transformed by 
the Kirsten-uas sarcoma virus as capable of reverting 
their transformed phenotype [3]. This cDNA was iso- 
lated, called Krev-1 (Kirsten-ras revertant) and was sug- 
gested to encode for a transformation suppressor anti- 
gen. At the same time, another group isolated 2 cDNAs 
coding for the Ras-related GTP-binding Rap1 proteins: 
rapla and raplb, and the rupla cDNA was identified as 
the Krev-2 cDNA [4,5]. However, apart from this puta- 
tive role of Rap1 proteins in suppressing transformation, 
their precise action mechanism remains under investiga- 
tion, contrary to their structural characteristics which 
have been extensively described. Thus, like Ras-p21 pro- 
teins, Rap1 proteins have been shown to display an ac- 
tive form that binds GTP, and an inactive form that 
binds GDP [6]. Rap1 proteins can be phosphorylated by 
a carp-dependent serine/threo~ne protein kinase 
(PKA) [7] in the serine 180 and 179 position for, respec- 
tively, Rapla [S] and Raplb [9]. 
The aim of the present study was to improve the un- 
derstanding of the role of Rap1 proteins, by exploring 
the regulation of their expression in cell proliferation 
induced by PDGF. For this purpose, we used a well- 
established proliferating model consisting of PDGF-in- 
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duced proliferation of SMC. We first explored untreated 
SMC for the presence of Rap1 proteins mainly by West- 
ern blotting and i~~opr~ipitation using a specific 
anti-Rap1 antibody. The effect of PDGF on SMC prolif- 
eration and rap1 expression was then assessed by testing 
(i) PDGF-induced mitogenic activity and (ii) PDGF-in- 
duced Rap1 protein and mRNA expressions. The results 
of these studies showed an up-regulation of both Rap1 
proteins and rapla mRNA species in PDGF BB-induced 
SMC proliferation. 
2. Materials and methods 
2.1. Cell et&we 
SMC were isolated from rat thoracic aorta and cultured according 
to Ross [IO]. Briefly, the me~um was cut into 2 mm long explants which 
were placed in culture flasks containing Ham’s FIO medium supple- 
mented with 20% foetal calf serum, 2 mM L-glutamine, 50 U/ml penicil- 
lin and 50 @ml streptomycin. SMC were cultured in an atmosphere 
of 5% CO, in air at 37°C. All the exneriments were uerformed with cells 
which had undergone less than 6 passages. 
PDGF AA and BB-induced mitogenic activity was assessed by meas- 
uring incorporation of [3H]th~idine into newly s~thetized DNA. 
SMC were seeded in L&well plates for 48 h, and then serum-deprived 
for 48 h. Next, recombinant PDGF AA (Genzyme, Cambridge, MA, 
USA) or BB (Serva, Heidelberg, achy) and 1 &iiml of [3HJthy- 
midiue (74 GBq/mmol, Amersham, UK) were added simultaneously for 
48 h at 37°C. After precipitation with 10% ice-cold trichloracetic acid 
for 10 min, cells were solubilized at room temperature with 200 mM 
N&H. Radioactivity was quantified in a /!I scintillation liquid counter 
(Beckman, Fullerton, CA, USA). 
2.3. ~ei~~ractionation 
Cells were washed in 17 mM HEPES pH 7.0, 160 mM KC1 and 0.05 
mM EGTA. They were resuspended in an ice-cold buffer containing 10 
mM HEPES pH 7.0, 10 mM KCl, 0.05 mM EGTA, 0.5 mM DTT, 10 
@ml leupepnn, 50 &ml aprotinin and 100 &ml SBTI. The homoge- 
nates were sonicated and centrifuged for 10 min at 1,000 x g and 4°C. 
An aliquot of cell lysate was taken-and remaining fraction WG ultracen- 
trifuged for 1 h at 100,000 x g and 4°C. The resulting pellet (mem- 
branes), the supematant (cytosol) and the lysate were stored frozen at 
-80°C. Proteins were quantified by the Bradford method, using rabbit 
gammaglobulins as standard [I 11. 
2.4. Western blotting 
After reduction, proteins were separated by 11% sodium dodecyl 
sulfate-polyac~lamide gel electrophoresis (SDS-PAGE) [ 121 and elec- 
troblotted onto nitrocellulose. The sheets were blocked for 2 h at room 
temperature by incubation in a buffer containing 10 mM Tris-HCl pH 
7.5, 150 mM NaCl, 0.1% Tween-20 (v/v), 0.5% BSA (w/v) and 0.5% 
gelatin (w/v), incubated for 2 h at room temperature with a 1:lOOO 
dilution of anti-Rap1 antibody in the same buffer. The specific anti- 
Rap1 antibody, which recognizes both Rapla and Raplb proteins was 
obtained as previously described [131 and amity-purified on an aga- 
rose column coupled to the immunizing peptide, The antibody binding 
was revealed by further incubation with [“‘I]protein A (0.1 pCi/ml, 
1110 MBqlmg, Amersham) and autoradio~aphy was performed at 
-80°C for 72 h. Rapt protein expression was quantified by densito- 
metric measurement of the radioactive bands using an LKB Ultroscan 
XL laser densitometer and results were analysed by a t-paired test. 
2.5. Rap1 protein immunoprecipitation 
The membrane fractions (300 pg) were phospho~lated in the pres- 
ence of 20 &ml of the catalytic subunit of PK.4 (C. Sub., Sigma, St 
Louis, MO; USA) and 6 mM ~Y-~~P]ATP (460 MBq/mmol, Am&sham) 
for IO min at 30°C as previously described 1141. PhosphoryIated pro- 
teins were then treated for immunoprecipitation using the anti-Rap1 
antibody, as previously described 11.51, separated by SDS-PAGE, elec- 
troblotted onto nitrocellulose and autoradiographed at-80°C. for l-5 
days. 
2.6. Polymerase chain reaction 
Total RNAs were isolated from SMC according to Chomczynski et 
Sacchi [16]. 500 ng of total RNA sample was denaturated by heating 
for 3 min at 75°C and annealed to the 3’ primers corresponding to 
rapla, rapfb [17j and SERCA 2b (sarc~ndoplasmic reticulum Ca’+ 
ATPase) [ 181, by slow cooling to 3O’C. Reverse transcription was car- 
ried out by adding 100 units of murine Moloney leukemia virus reverse 
transcriptase (MMLV-RT, Gibco-BRL, Paisley, Scotland) for I h at 
42°C in PCR buffer containing 10 mM Tris-HCl pH 8.3,50 mM KCL, 
1.5 mM MgCl,, 0.001% gelatin and 2.5 mM each of dATP, dCTP, 
dGTP and dTTP, in a total volume of 10 ~1. Reverse transcription was 
terminated by inactivating the MMLV-RT for 10 min at 95°C. The 
PCR was performed in the same reaction mixture, adjusted to 50~1 with 
the PCR buffer containing the 5’ primers (rapla-lb and SERCA 2b). 
PCR was initiated by adding 1.25 units of Taq polymerase (Thermus 
aquaticus, Eurogentec, Seraing, Belgium) and conducted in an auto- 
mated thermocycler (Techne OSI, Cambridge, UK) for 30 cycles each 
consisting of denaturation at 95°C for 45 .s? annealing at 55°C for 1 min 
and extension at 70°C for 2 min. 
2.7. Southern blotting 
The PCR products were submitted to electrophoresis on a 2% ethid- 
ium bromide-stained agarose gel and transferred onto Biohylon Z+ 
membranes (Bioprobe, Montreuil sous Bois, France). Membranes were 
prehybridized for 4 h at WC in 5 x sodium salt citrate buffer (SSC), 
IO x Denhart’s solution (0.2% (w/v} BSA, 0.2% (w/v) Ficoll and 0.2% 
(w/v) pol~inylpyrrolidone), 0.1% SDS and 250 &ml denatured her- 
ring sperm DNA. Hybridization was performed by adding 2.10’ cpm/ml 
random primed labelled cDNA probes in the same solution overnight 
at 65°C. The rapla and raplb probes were respectively a 760 and a 730 
bp I;lindIII/EcoRI fragment otally covering human rapla and raplb 
cDNAs [4,5]. The SERCAZb probe was an 848 bp cDNA fragment, 
obtained from a human platelet cDNA library f19]. Membranes were 
washed twice in 1 x SSC, 0.1% SDS for 20 min at 65”C, and twice in 
0.1 x SSC, 0.1% SDS for 20 min at 65°C and autoradiographed on 
X-Omat AR tilms, at -8O’C. RT-PCR products were quantified and 
results analysed as described in section 2.4. 
3. Results 
3.1. Evidence for the presence of Rap1 proteins in SMC 
To detect Rap1 proteins, we first proceeded to SMC 
fractionation and submitted the resulting fractions to 
Western blotting using the anti-Rap1 antibody (Fig. 1A). 
Whereas no Rap1 proteins were detectable in the lysate 
(lane I), ~ompa~son of the cytosol (lane 2) and the mem- 
branes (lane 3) clearly demonstrated the presence of a 24 
kDa protein only in the membranes. Consequently, sub- 
sequent experiments were carried out using this mem- 
brane fraction, To confirm that the 24 kDa protein was 
identical to Rap1 proteins, we took advantage of the 
evidence that in human platelets {14] these proteins dis- 
played an electrophoreti~ mobility shift which varied, 
depending on reducing or non-reducing conditions. Ac- 
cordingly, as shown in Fig. lB, non-reduced or reduced 
SMC membrane proteins were studied. Under non-re- 
ducing conditions, anti-Rap1 antibody reacted with a 22 
kDa protein (lane 1) and under reducing conditions, with 
a 24 kDa protein (lane 2). Lastly, we established that this 
24 kDa protein and Rap1 proteins were identical, by 
performing their PKA-dependent phosphorylation fol- 














Fig. 1. Evidence for the presence of Rap1 proteins in SMC membranes. (A) Subcellular distribution of Rap1 proteins. SMC were fractionated as 
described in section 2 and each protein sample (100 pug) was separated by 11% SDS-PAGE followed by Western blotting, performed using anti-Rap1 
antibody. Lane 1, SMC lysate fraction; lane 2, SMC cytosol fraction; lane 3, SMC membrane fraction. Rap1 protein molecular masses were estimated 
in kDa using standard markers (69, BSA; 42, ovalbumin; 3 1, bovine carbonic anhydrase; 21, soybean trypsin inhibitor; and 14, lysozyme). This figure 
is typical of 3 experiments. (B) Rap1 protein el~tropho~tic mobility shift. Membrane proteins (100 lug) were incubated for 5 min at 100°C with 
or without 5% /I-mercaptoethanol and treated as described in A. Lane 1, non reduced SMC membrane proteins; lane 2, reduced SMC membrane 
proteins. Rap1 protein molecular masses were estimated in kDa using the same standard markers as in A. This figure is typical of 4 experiments. 
(C) Immunoprecipitation by anti-Rap1 antibody of the 24 kDa membrane CAMP-induced phosphoprotein. SMC membrane proteins (300 pg) were 
phosphorylated and then immunoprecipitated using the anti-Rap1 antibody, as described in section 2. Lane 1, CAMP-induced phosphorylation of 
SMC membrane fraction in the absence of C. Sub.; lane 2, CAMP-induced phospho~lation of SMC membrane fraction in the presence of C. Sub.; 
lane 3, immunopr~pitation of non-phospho~lated proteins (control}, using the anti-Rap1 antibody; lane 4, immunoprecipitation of the CAMP- 
induced phosphorylated proteins, using the anti-Rap1 antibody. Rap1 protein molecular masses were estimated in kDa using the same standard 
markers as in A. This figure is typical of 2 experiments. 
lowed by i~unopr~ipi~tion of the resulting 
phosphoproteins, using the anti-Rap1 antibody (Fig. 
1C). Lanes 1 and 2 show the phosphorylation of SMC 
membrane proteins in the absence of C. Sub. (lane 1) or 
in its presence (lane 2), whereas lanes 3 and 4 show the 
corresponding i~unoprecipitates. Comparison of 
lanes 2 and 4 established beyond doubt that the 24 kDa 
CAMP-induced phosphoprotein is immunoprecipitated 
by the anti-Rap1 antibody (lane 4). Consequently, the 
results of these experiments taken together clearly estab- 
lished the expression and identity of Rap1 proteins in 
SMC membranes. 
3.2. PDGF-induced SMC mitogenic activity 
Before exploring the effect of PDGF on Rap1 protein 
expression, we tested both PDGF AA and BB-induced 
mitogenic activity, by measuring [3H]thymidine incorpo- 
ration into newly synthetized DNA (Fig. 2). PDGF AA 
induced very low 13H]th~~ne incorporation, which 
reached a plateau at 235% of the control value for a 
concentration of IO ng/ml, thus demonstrating very weak 
mitogenic activity. In contrast with PDGF BB, [3H]thy- 
midine incorporation rose in a dose-dependent manner 
for con~ntrations of 0 to 10 &ml and this rise reached 
a plateau at 520% of the control value, for 10 r&ml. 
Consequently, these conditions, i.e. SMC treated with 10 
&ml of PDGF AA or BB for 48 h, were used for subse- 
quent studies. 
g O s 10 15 20 PDGF concrentfation (#@ml) 
Fig. 2. PDGF AA and PDGF BB-induced SMC mitogenic activity. 
After 48 h of serum deprivation, SMC were incubated with rising 
concentrations (0 to 20 &ml) of either PDGF AA (0) or PDGF BB 
(o), and with 1 &i/ml of [3H]th~id~e. Results are expressed as 
percentage of [3~th~idine incorporation relative to a control without 
growth factor (100%) and are representative of 3 experiments con- 
ducted in duplicate. 
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Fig. 3. Effect of PDGF AA and BB on Rap1 protein expression. After 48 h serum deprivation, SMC were grown for 48 h in the presence of IO ng/ml 
of PDGF AA, or PDGF BB, or in the absence of PDGF. Membrane proteins (100 pg) were treated as described in Fig. 1A. (A) Western blotting. 
Lane 1, membranes i olated from untreated SMC; lane 2, membranes i olated from SMC stimulated by PDGF AA; lane 3, membranes i olated from 
SMC stimulated by PDGF BB. Rap1 protein molecular masses were estimated in kDa using the same standard markers as in Fig. IA. This figure 
is typical of 4 experiments. (B) Western blot densitometry. Autoradiograms were scanned using a laser densitometer as described in section 2. For 
each experiment, he control values obtained without growth factor (bar 1) were arbitrarily taken as 100%. The results (bars 2 and 3) are expressed 
as percentage of Rap1 protein expression versus the control (100%) and are the means f S.E.M. of 4 experiments. ( **I’5 0.005). 
3.3. Effect of PDGF AA and BB on Rap1 protein 
expression in SMC 
Then, we explored the regulation of Rap1 protein ex- 
pression upon stimulation with PDGF AA or BB. For 
this purpose, membrane fraction proteins were isolated 
from PDGF AA or BB-treated or untreated SMC and 
analysed by Western blotting using the anti-Rap1 anti- 
body (Fig. 3A). Whereas PDGF AA had no detectable 
effect on Rap1 protein expression in SMC (lane 2), com- 
pared to control untreated SMC (lane l), this expression 
increased upon stimulation with PDGF BB (lane 3). 
Rap1 protein expression was then quantified by den- 
sitometric scanning (Fig. 3B). PDGF AA (bar 2) had no 
effect on Rap1 protein expression (99% + 360/o), as com- 
pared to control (bar I), whereas PDCF BB significantly 
increased this expression (bar 3), which reached 
260% rt 70% of the control value. 
3.4. Time-~pe~de~t effect of PDGF BB on Rap1 protein 
expression 
In order to define whether this regulation was related 
to proliferation, membrane fraction proteins were iso- 
lated from SMC treated with PDGF BB for 6 h, 24 h and 
48 h or from untreated SMC and analysed as above (Fig. 
4A). No apparent change in Rap1 protein expression 
was observed after 6 h (lane 2) or 24 h (lane 3) compared 
to control untreated SMC (lane 1). In contrast, after 48 
h of PDGF BB stimulation, this expression increased 
(lane 4). Rap1 protein expression was then quantified by 
densitometri~ scanning (Fig. 4B). PDGF BB had no ef- 
fect on Rap1 protein expression after 6 h (bar 2, 
94% k 11%) or 24 h of PDGF BB stimulation (bar 3, 
103% + 6%). However, 48 h of PDGF BB stimulation 
significantly rose Rap1 protein expression, which 
reached 191% -t 22% of the control value (bar 4). 
3.5. Effect of PDGF BB on rapla and raplb mRNA 
expression in SMC 
Lastly, we tried to define how the amount of Rap1 was 
regulated by studying the effect of PDGF BB on rapl 
mRNA species. Alternatively, this study gave the oppor- 
tunity to differentiate between the two rap1 mRNAs 
(rapla and raplb) because of the availability of specific 
cDNA probes, in contrast with the anti-Rap1 antibody. 
For this analysis, we devised co-amplification experi- 
ments by RT-PCR of either rapla and raplb mRNAs, 
with an internal control mRNA, which was previously 
demonstrated unmodified upon PDGF BB-induced 
SMC proliferation [ZO] and termed SERCAZb. Fig. 5 
shows the Southern blot of rapla and SERCA2b co- 
amplification, conducted on total RNAs extracted from 
untreated SMC (lane 1) and SMC treated by PDGF BB 
for 48 h (lane 2) in the presence of MMLV-RT. No 
amplification product was found in the absence of 
MMLV-RT (lane 3). Two DNA fragments of 362 bp and 
270 bp, respectively, corresponding to rapla and 
SERCA2b were visible in untreated (lane 1) and in 
PDGF BB-stimulated SMC (lane 2). As regards the ef- 
fect of PDGF BB, whether it did not modify the 
SERCA2b mRNA expression, as expected, Fig. 5 clearly 
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Fig. 4. Time-dependent effect of PDGF BB on Rap1 protein expression. After 48 h serum deprivation, SMC were grown for 6 h, 24 h and 48 h in 
the presence of 10 r&ml of PDGF BB, or in the absence of PDGF. Membrane proteins (100 pg) were treated as described in Fig. 1A. (A) Western 
blotting. Lane 1, membranes i olated from untreated SMC; lane 2, membranes i olated from SMC stimulated by PDGF BB for 6 h; lane 3, membranes 
isolated from SMC stimulated by PDGF BB for 24 h; lane 4, membranes i olated from SMC stimulated by PDGF BB for 48 h. Rap1 protein molecular 
masses were estimated in kDa using the same standard markers as in Fig. 1A. This figure is typical of 4 experiments. (B) Western blot densitometry. 
Autoradiograms were scanned using a laser densitometer as described in section 2. For each experiment, he control values obtained without growth 
factor (bar 1) were arbitrarily taken as 100%. The results (bars 2,3 and 4) are expressed as percentage of Rap1 protein expression versus the control 
(100%) and are the means 5~ S.E.M. of 4 experiments. pP--0.01). 
shows a significant increase in rapla mRNA species 
(compare lanes 1 and 2). Similar experiments carried out 
on ruplb did not demonstrate any effect on this mRNA 
species expression (data not shown). 
These rapla, rapfb and SERCA2b mRNA expressions 
rapla 
SERCA22b 
- 362 bp 
- 270 bp 
123 
Fig. 5. Effect of PDGF BB on rapla mRNA expression. After 48 h 
serum-deprivation, SMC were grown for 48 h in the presence of 10 
r&ml of PDGF BB, or in the absence of PDGF and total RNAs were 
extracted as previously described. 500 ng of total RNA was submitted 
to comparative co-amplification by RT-PCR of rupla and SERCA 2b 
mRNA species, using a mixture of the different primers. The amplifica- 
tion products were analysed by Southern blotting, as described in sec- 
tion 2, using a mixture of the “P-1abelled rapla and SERCA2b cDNA 
probes. Lane 1, amplification products of total RNAs extracted from 
untreated SMC; lane 2, amplitication products of total RNAs extracted 
from SMC stimulated by PDGF BB for 48 h; lane 3, control amplifica- 
tion products of total RNAs, in the absence of MMLV-RT. Numbers 
on the right side of the figure indicate the size of the amplification 
products in base pairs (bp). This figure is representative of 3 experi- 
ments. 
were further quantified by densitometric scanning and 
the relative expressions of rapla and rapfb were esti- 
mated (Table 1). It appeared that: (i) the rapla and raplb 
mRNA expressions were identical in untreated SMC 
(0.97 f 0.03; 0.99 ? 0.13), and (ii) PDGF BB specifically 
induced a 1.5fold increase in rapla mRNA expression 
(0.97 f: 0.03 versus 1.42 rt 0.19), as raplb mRNA expres- 
sion was not modified (0.99 f 0.13 versus 0.94 f 0.03). 
4. Discussion 
This work clearly shows that: (i) Rap1 proteins are 
expressed in rat vascular SMC membrane fractions, (ii) 
their expression is up-regulated by PDGF BB, and (iii) 
this up-regulation of Rap1 proteins was further corre- 
lated with an increase in rapla mRNA species. As far as 
we know this is the first demonstration of the regulation 
of Rap1 proteins in a proliferating model. 
Table 1 
PDGF BB effect on the relative expressions of rapla and raplb mRNA 
species 
- PDGF BB + PDGF BB 
raplalSERCA2b 0.97 + 0.03 1.42 + 0.19** 
raalblSERCA2b 0.99 + 0.13 0.94 + 0.03 
Southern blot autoradiograms were scanned using a laser densitome- 
ter, as described in section 2. The results are expressed as ratio of 
rapllSERCA2b mRNA expressions and are the means + S.E.M. of 3 
experiments. l*PsO.Ol . 
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The identification of Rap1 proteins in rat SMC is 
based on fi) the use of a specific anti-Rap1 antibody, (ii) 
Rap1 protein Pi-de~ndent phosphorylation and 
their subsequent i~~opr~ipitatio~, and (iii) the spe- 
cific electrophoretic shift in Rap1 protein migration de- 
pending on reducing conditions. As regards this shift in 
Rap1 protein mobility on SDS-PAGE, it is now known 
that the structure of these proteins was stabilized by 
several intrachain disulfide bridges (3 for Rapla and 2 
for Rap1 b), which were cleaved under reducing condi- 
tions; hence we could believe that this cleavage probably 
involved a change in the tertiary conformation of the 
protein structure. Thus, Rap1 proteins are expressed in 
SMC, appeared associated to the membrane fraction, in 
a total agreement with the recent location of these pro- 
teins in several cell types [13,21,22]. 
In the second part of this study, we first investigated 
the effects of PDGF AA and BB on SMC proliferation 
and Rap1 protein expression. Thus, we showed that only 
PDGF BB exhibited significant mitogenic activity as well 
as an up-regulation of total Rap1 protein expression. 
The most plausible explanation for our observation that 
PDCF AA had no si~i~cant effect on ~togenic activity 
and did not affect Rap1 protein expression is that it only 
reflects the presence of an ins~cient number of PDGF 
AA receptors. Indeed, in rat SMC, 5,000 PDGF AA and 
31,000 PDGF BB binding sites per cell have been found 
[23]. Subsequent time-course studies showed that the in- 
crease in Rap1 protein expression only occurred after 48 
h of stimulation by PDGF BB, suggesting that this up- 
regulation requires protein neosynthesis and is related to 
the state of cell proliferation. Lastly, through mRNA 
studies, we defined that (i) the Rap1 protein up-regula- 
tion was correlated with an increase in mRNA expres- 
sion, suggesting that PDGF BB acts at the .papl tran- 
scriptional evel, and (ii) that the Rap1 protein concerned 
by the regulation should be the Rapla protein. 
So, these results allowed us to suggest that Rapla 
protein can effectively be involved in modulating cell 
proliferation mechanisms. Indeed, PDGF BB is known 
to induce a mitogenic pathway which involves the activa- 
tion of Ras [24] and of its potential effector, the Ras- 
specific GTPase activating protein (Ras-GAP) 125,261. In
addition, Rap1 proteins exhibit a high affinity for the 
Ras-GAP /27] and the GTP-binding form of Rap1 
protein was recently demonstrated to interfere with 
downstream signalling from Ras to the nucleus [ZS]. 
Therefore, it appears that Rap-GTP could be a potent 
antagonist of Ras by competing with Ras for its effector 
and then could prevent further signal transduction to- 
wards the nucleus. Hence, it is conceivable that in non- 
transformed cells, such as PDGF BB-induced proliferat- 
ing SMC studied here, these Rap1 proteins might play 
a role in regulating cell proliferation by preventing cells 
from entering into anarchic division cycles. 
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